TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
DSGN

Design Therapeutics Inc

Healthcare · Biotechnology · —

12.40$ -6.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow DSGN
Line item 2019 2020 2021 2022 2023 2024 2025
+0.0% +2,480.0% +214.7% +32.3% +11.0% +4.4%
+942.0% +133.0% +19.8% -0.1% +11.3%
+338.9% +1,024.5% +133.1%
-144.7% +42.7% -63.5% -236.4%
+0.0% +1,923.7% -40.3% -72.1% +32.8% -43.2%
+0.0% +59.8% +312.0% -16.3% -47.9%
+74.7% -10.0% +56.4% +36.1%
-202.0% -100.0%
+22,620.4% +751.5% -99.9% +208.1% -29.1% +4,917.2%
+3,938.6% +12,766.6% -191.9% -518.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?